Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Stomach trouble? scientists check body fat and muscle in new study

NCT ID NCT07196735

Knowledge-focused Sponsor: Universitair Ziekenhuis Brussel Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether women with functional dyspepsia (a condition causing stomach pain and discomfort without a clear cause) have different body composition than healthy women. Researchers will use a simple, non-invasive test called bio-electrical impedance to measure fat mass, fat-free mass, and phase angle. The goal is to better understand the condition, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

female patients with or without FD between 18 and 75 years

Ages

18 to 75 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 18 - 75 years * Fulfilling the ROME IV criteria for functional dyspepsia (for FD patients) * FD unexplained by upper GI endoscopy during the past 12 months (mild gastritis allowed) (for FD patients). Exclusion Criteria: * Clinical suspicion of an organic disorder different from FD (patients can be included when this disorder had been excluded); * Abnormality on upper GI endoscopy other than mild gastritis (for FD patients). * Known reflux oesophagitis Los Angeles grade C or D, known Barrett oesophagus, peptic stricture. * H pylori infection, unless treated at least 6 months before; * Known inflammatory bowel disorder; * Known major intestinal motility disorder; * Alcohol (defined as more than 14 U per week) or other substance abuse; * Active psychiatric disorder; * Known systemic or auto-immune disorder with implication for the GI system; * Prior abdominal surgery (with the exception of cholecystectomy or ap-pendectomy); * Any prior diagnosis of cancer other than basocellular carcinoma; * Current chemotherapy; * History of gastro-enteritis in the past 12 weeks; * Dietary supplements unless taken at a stable dose for more than 12 weeks; * Treatment with neuromodulators (one neuromodulator taken at a sta-ble dose for more than 12 weeks is allowed); * Treatment with PPI's during the past 8 weeks * Pregnancy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dyspepsia functional gastric disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BIA Fat free mass Fat mass Functional dyspepsia Phase angle

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • UZ Brussel

    RECRUITING

    Brussels, 1090, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.